These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33004129)

  • 1. Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis.
    Peretto G; Sala S; Basso C; Rizzo S; Radinovic A; Frontera A; Limite LR; Paglino G; Bisceglia C; De Luca G; Campochiaro C; Sartorelli S; Palmisano A; Esposito A; Busnardo E; Villatore A; Baratto F; Cireddu M; Marzi A; D'Angelo G; Gulletta S; Vergara P; De Cobelli F; Dagna L; Mazzone P; Della Bella P
    J Am Coll Cardiol; 2020 Oct; 76(14):1644-1656. PubMed ID: 33004129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis.
    Kaur D; Roukoz H; Shah M; Yalagudri S; Pandurangi U; Chennapragada S; Narasimhan C
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):612-620. PubMed ID: 31916658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging and epicardial substrate ablation of ventricular tachycardia in patients late after myocarditis.
    Maccabelli G; Tsiachris D; Silberbauer J; Esposito A; Bisceglia C; Baratto F; Colantoni C; Trevisi N; Palmisano A; Vergara P; De Cobelli F; Del Maschio A; Della Bella P
    Europace; 2014 Sep; 16(9):1363-72. PubMed ID: 24558183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis.
    Naruse Y; Sekiguchi Y; Nogami A; Okada H; Yamauchi Y; Machino T; Kuroki K; Ito Y; Yamasaki H; Igarashi M; Tada H; Nitta J; Xu D; Sato A; Aonuma K
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):407-13. PubMed ID: 24837644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy.
    Chopra N; Tokuda M; Ng J; Reichlin T; Nof E; John RM; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):602-8. PubMed ID: 24576211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-refractory ventricular tachycardias after myocarditis: endocardial and epicardial radiofrequency catheter ablation.
    Dello Russo A; Casella M; Pieroni M; Pelargonio G; Bartoletti S; Santangeli P; Zucchetti M; Innocenti E; Di Biase L; Carbucicchio C; Bellocci F; Fiorentini C; Natale A; Tondo C
    Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):492-8. PubMed ID: 22294614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial adipose tissue thickness as an independent predictor of ventricular tachycardia recurrence following ablation.
    Sepehri Shamloo A; Schoene K; Stauber A; Darma A; Dagres N; Dinov B; Bertagnolli L; Hilbert S; Müssigbrodt A; Husser D; Bollmann A; Hindricks G; Arya A
    Heart Rhythm; 2019 Oct; 16(10):1492-1498. PubMed ID: 31202898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.
    Oloriz T; Silberbauer J; Maccabelli G; Mizuno H; Baratto F; Kirubakaran S; Vergara P; Bisceglia C; Santagostino G; Marzi A; Sora N; Roque C; Guarracini F; Tsiachris D; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):414-23. PubMed ID: 24785410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
    Koplan BA; Soejima K; Baughman K; Epstein LM; Stevenson WG
    Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility.
    Piers SR; Leong DP; van Huls van Taxis CF; Tayyebi M; Trines SA; Pijnappels DA; Delgado V; Schalij MJ; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):513-21. PubMed ID: 23619893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach?
    Reithmann C; Herkommer B; Fiek M
    Clin Res Cardiol; 2016 Oct; 105(10):827-37. PubMed ID: 27294860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy.
    Jin Q; Jacobsen PK; Pehrson S; Chen X
    Clin Cardiol; 2017 Nov; 40(11):1083-1089. PubMed ID: 28817194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined analysis of unipolar and bipolar voltage mapping identifies recurrences after unmappable scar-related ventricular tachycardia ablation.
    Yalin K; Golcuk E; Bilge AK; Aksu T; Buyukbayrak H; Tiryakioglu SK; Emet S; Adalet K
    Europace; 2015 Oct; 17(10):1580-6. PubMed ID: 25750215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological characteristics and radiofrequency ablation of sustained monomorphic ventricular tachycardia in adult patients with isolated ventricular noncompaction.
    Li Y; Xue Y; Yu J; Jiang C; Wang Z; Mbai M; Tholakanahalli V; Benditt DG; Li JM
    J Interv Card Electrophysiol; 2018 Jun; 52(1):117-125. PubMed ID: 29582363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation.
    Vergara P; Trevisi N; Ricco A; Petracca F; Baratto F; Cireddu M; Bisceglia C; Maccabelli G; Della Bella P
    J Cardiovasc Electrophysiol; 2012 Jun; 23(6):621-7. PubMed ID: 22486970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of catheter ablation in post-infarction recurrent ventricular tachycardia.
    Haanschoten DM; Smit JJJ; Adiyaman A; Ramdat Misier AR; Hm Delnoy PP; Elvan A
    Scand Cardiovasc J; 2019 Apr; 53(2):62-70. PubMed ID: 30916588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
    Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
    Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Prognostic Heart Failure Models in Patients With Nonischemic Cardiomyopathy Undergoing Ventricular Tachycardia Ablation.
    Muser D; Liang JJ; Castro SA; Lanera C; Enriquez A; Kuo L; Magnani S; Birati EY; Lin D; Schaller R; Supple G; Zado E; Garcia FC; Nazarian S; Dixit S; Frankel DS; Callans DJ; Marchlinski FE; Santangeli P
    JACC Clin Electrophysiol; 2019 Jul; 5(7):801-813. PubMed ID: 31320008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
    Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation of ventricular tachycardia in patients with postinfarction left ventricular aneurysm.
    Amin M; Farwati M; Hilaire E; Siontis KC; Madhavan M; Kapa S; Mulpuru SK; Deshmukh AJ; Cha YM; Friedman PA; Munger T; Asirvatham SJ; Killu AM
    J Cardiovasc Electrophysiol; 2021 Dec; 32(12):3156-3164. PubMed ID: 34664765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.